Integrated Filing — IndAS



General information about company

Scrip Code 532300
NSE Symbol WOCKPHARMA
MSEI Symbol NA
ISIN INE049B01025
Name of company Wockhardt Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 03-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 29-10-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 03-11-2025   11:45:00
End date and time of board meeting 03-11-2025   14:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 13-11-2024
Indicate Company website link for updated RPT policy of the Company https://www.wockhardt.com/wp-content/uploads/2022/08/prt-31122.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Not Applicable as there is no default on loans and the company has no outstanding debt securities as on 30.09.2025.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 38,000.00 79,300.00
Other income 3,000.00 5,500.00
Total income 41,000.00 84,800.00
2 Expenses
(a) Cost of materials consumed 7,500.00 14,900.00
(b) Purchases of stock-in-trade 5,100.00 9,000.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (5,500.00) (5,500.00)
(d) Employee benefit expense 8,800.00 15,600.00
(e) Finance costs 4,400.00 8,500.00
(f) Depreciation, depletion and amortisation expense 4,500.00 9,100.00
(f) Other Expenses
1 Other expenses 10,800.00 20,900.00
Total other expenses 10,800.00 20,900.00
Total expenses 35,600.00 72,500.00
3 Total profit before exceptional items and tax 5,400.00 12,300.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 5,400.00 12,300.00
6 Tax expense
7 Current tax 0.00 0.00
8 Deferred tax 0.00 0.00
9 Total tax expenses 0.00 0.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 5,400.00 12,300.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 5,400.00 12,300.00
17 Other comprehensive income net of taxes 0.00 0.00
18 Total Comprehensive Income for the period 5,400.00 12,300.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 8,100.00 8,100.00
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 3.26 7.51
Diluted earnings (loss) per share from continuing operations 3.25 7.5
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 3.26 7.51
Diluted earnings (loss) per share from continuing and discontinued operations 3.25 7.5
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1.The results were reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on November 03, 2025. The results have been subjected to limited review by the Statutory Auditors of the Company. 2.During the quarter ended September 30, 2025 , the Company has allotted 6,600 ( Year to date: 6,600) Equity shares of face value of Rs. 5/- each pursuant to exercise of employee stock options. 3.In Row 68 and 69 EPS (Basic and Diluted) is not annualised. 4.The Company is exclusively into Pharmaceutical business segment.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 1,18,300.00
Capital work-in-progress 10,000.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 25,100.00
Intangible assets under development 1,12,500.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 29,700.00
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets 5,500.00
Total non-current financial assets 35,200.00
Deferred tax assets (net) 25,000.00
Other non-current assets 18,400.00
Total non-current assets 3,44,500.00
2 Current assets
Inventories 50,100.00
Current financial asset
Current investments 69,600.00
Trade receivables, current 73,100.00
Cash and cash equivalents 5,900.00
Bank balance other than cash and cash equivalents 5,100.00
Loans, current 0.00
Other current financial assets 9,500.00
Total current financial assets 1,63,200.00
Current tax assets (net)
Other current assets 26,000.00
Total current assets 2,39,300.00
3 Non-current assets classified as held for sale 10,400.00
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 5,94,200.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 8,100.00
Other equity 2,80,500.00
Total equity attributable to owners of parent 2,88,600.00
Non controlling interest
Total equity 2,88,600.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 1,38,200.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 16,600.00
Total non-current financial liabilities 1,54,800.00
Provisions, non-current 3,100.00
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 1,57,900.00
Current liabilities
Current financial liabilities
Borrowings, current 58,100.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 5,400.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 42,300.00
Total Trade payable 47,700.00
Other current financial liabilities 23,600.00
Total current financial liabilities 1,29,400.00
Other current liabilities 14,900.00
Provisions, current 3,200.00
Current tax liabilities (Net) 200.00
Deferred government grants, Current
Total current liabilities 1,47,700.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 3,05,600.00
Total equity and liabilites 5,94,200.00
Disclosure of notes on assets and liabilities Textual Information(1)



Text Block

Textual Information(1) Notes to Assets Liabilities: 1. Property, Plant and Equipment of Rs.1183 crore includes Right of use assets amounting to Rs.243 crore. 2. Non-current Investment includes Investments in subsidiaries Rs 297 crore and other invesments Rs. 0.45 crore. 3. Other non-current assets of Rs.184 crore includes Non-current tax assets (net) amounting to Rs. 76 crore. 4. Other non-current financial liabilities consists Lease liabilities amounting to Rs. 166 crore. 5. Other current financial liabilities of Rs. 236 crores include Lease liabilities amounting to Rs. 76 crore. 6. Non-current assets classified as held for sale represents Assets classified as held for sale. Please also, additionally refer to the Statement of Standalone Audited Results for the quarter and half year ended September 30, 2025 as attached to the Outcome of Board Meeting. Notes to Cash Flow Statements: 1.The above statement of cash flows has been prepared under the indirect method as set out in Ind AS 7 'Statement of Cash Flows'. 2. Repayment of lease liabilities consists of: Payment of interest Rs. 12 crore (Previous period - Rs. 14 crore) Payment of Principal Rs. 27 crore (Previous period - Rs. 24 crore) 3. Adjustments for unrealised foreign exchange losses gains consists of Net foreign exchange fluctuation (gain)/Loss, net. 4. Other Cash inflow (outflow) of cash consists of Margin money under lien and Bank balances (other than cash and cash equivalents) Rs. 25 Crore, Guarantee Commission received Rs. 3 crore and Purchase of current investments (net) Rs. 260 Crore. 5. Proceeds from issuance of shares has been netted off with transaction cost related to right issue/QIP concluded during earlier years of Rs. 1 Crore. This also includes proceeds from issuance of equity Share capital under ESOS Rs 0.003 crore. 6. Proceeds from borrowing amounting to Rs. 562 Crore consists of loan from Related Parties- Long term of Rs. 12 Crore. 5.Repayment from borrowing consists of Repayment of long term borrowings Rs. 80 Crore , Repayment of loan taken from Related Parties long term Rs. 32 Crore and short term borrowing( net ) Rs 9 crore. 7. Decrease in loans and advances and other asset in row no 24 includes decrease in loans and other assets of Rs 57 crores. 8.Other adjustments for non cash items includes Allowance for expected credit loss, doubtful advances and bad debts Rs. 7 crore, profit on sale of fixed assets (net) Rs. 14 Crore and Gain on sale of investment Rs. 9 crore. 9.Adjustments for fair value losses (gains) Rs.5 Crore consists of Fair valuation impact on investments. 10.Aggregated/ segregated in accordance with the prescribed format and to the extent is the requirement of the accounting standard. Please also, additionally refer to the Statement of Standalone Audited Results for the quarter and half year ended September 30, 2025 as attached to the Outcome of Board Meeting



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to Profit or Loss - (charge)/ credit (consisting of re-measurement of net defined benefit (liability) / asset) (22.00) (45.00)
2 Income tax relating to items that will not be reclassified to Profit or Loss - credit/(charge) 0.00 0.00
3 Rounding Off 22.00 45.00
Total Amount of items that will not be reclassified to profit and loss 0.00 0.00
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 0.00 0.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 12,300.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 8,500.00
Adjustments for decrease (increase) in inventories (7,500.00)
Adjustments for decrease (increase) in trade receivables, current (9,800.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 5,700.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (600.00)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (5,800.00)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 9,100.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (1,800.00)
Adjustments for dividend income 0.00
Adjustments for interest income 200.00
Adjustments for share-based payments 100.00
Adjustments for fair value losses (gains) (500.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (1,600.00)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (4,400.00)
Net cash flows from (used in) operations 7,900.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 200.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 7,700.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 1,400.00
Purchase of property, plant and equipment 6,200.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 10,000.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 100.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (23,200.00)
Net cash flows from (used in) investing activities (37,900.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares (100.00)
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 56,200.00
Repayments of borrowings 12,100.00
Payments of lease liabilities 3,900.00
Dividends paid 0.00
Interest paid 7,500.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 32,600.00
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 2,400.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 2,400.00
Cash and cash equivalents cash flow statement at beginning of period 3,500.00
Cash and cash equivalents cash flow statement at end of period 5,900.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M S K C & Associates LLP Yes 30-09-2026


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising QIP
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 11-11-2024
Amount Raised 1,00,000.00
Report filed for Quarter ended 30-09-2025
Monitoring Agency Applicable
Monitoring Agency Name, if applicable CRISIL RATINGS LIMITED
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation NA
Comments of the Audit Committee after review NIL
Comments of the auditors, if any NIL
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Repayment and / or pre – payment, in full or part, of certain borrowings availed by the Company. NO 50,000.00 0.00 49,131.00 0.00 During the quarter ended September 30, 2025, mutual funds held by the Company were redeemed and these proceeds were directly credited to its cash credit/current accounts instead of being transferred to the Monitoring account of the Company. Further, during the reported quarter, the Company had utilized a total sum of Rs 157.61 crores, out of the credited issue proceeds, towards the stated objects of the issue through these accounts directly, for operation convenience.
2 Funding of Capital expenditure, investment in research and development and incidential expenses NO 25,000.00 0.00 5,250.00 0.00 During the quarter ended September 30, 2025, mutual funds held by the Company were redeemed and these proceeds were directly credited to its cash credit/current accounts instead of being transferred to the Monitoring account of the Company. Further, during the reported quarter, the Company had utilized a total sum of Rs 157.61 crores, out of the credited issue proceeds, towards the stated objects of the issue through these accounts directly, for operation convenience.
3 General Corporate Purposes NO 22,397.00 22,779.00 19,687.00 0.00 During the quarter ended September 30, 2025, mutual funds held by the Company were redeemed and these proceeds were directly credited to its cash credit/current accounts instead of being transferred to the Monitoring account of the Company. Further, during the reported quarter, the Company had utilized a total sum of Rs 157.61 crores, out of the credited issue proceeds, towards the stated objects of the issue through these accounts directly, for operation convenience.


Signatory Details

Name of signatory Rashmi Mamtura
Designation of person Company Secretary and Compliance Officer
Place Mumbai
Date 03-11-2025




Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Wockhardt Limited Wockhardt Bio Ag Subsidiary Any other transaction Purchase of Intellectual Property 4,33,674.00 Approved 14,894.00 0.00 0.00 Textual Information(1)
2 Wockhardt Limited CP Pharmaceuticals Limited Step down subsidiary Purchase of goods or services 4,33,674.00 Approved 340.00 0.00 0.00
3 Wockhardt Limited Wockhardt Bio Ag Subsidiary Sale of goods or services 4,33,674.00 Approved 4,753.00 0.00 0.00
4 Wockhardt Limited Wockhardt Bio Ag Subsidiary Sale of fixed assets 4,33,674.00 Approved 4,219.00 0.00 0.00
5 Wockhardt Limited CP Pharmaceuticals Limited Step down subsidiary Sale of goods or services 4,33,674.00 Approved 15.00 0.00 0.00
6 Wockhardt Limited Wockhardt UK Limited Step down subsidiary Sale of goods or services 4,33,674.00 Approved 18.00 0.00 0.00
7 Wockhardt Limited Wockhardt USA LLC Step down subsidiary Sale of goods or services 27,900.00 Approved 4.00 0.00 0.00
8 Wockhardt Limited Wockhardt Bio Ag Subsidiary Sale of goods or services 4,33,674.00 Approved 188.00 0.00 0.00
9 Wockhardt Limited Pinewood Laboratories Ltd Step down subsidiary Sale of goods or services 4,33,674.00 Approved 24.00 0.00 0.00
10 Wockhardt Limited Morton Grove Pharmaceuticals, Inc. Step down subsidiary Sale of goods or services 27,900.00 Approved 1.00 0.00 0.00 Textual Information(2)
11 Wockhardt Limited Wockhardt Bio (R) LLC Step down subsidiary Sale of goods or services 27,900.00 Approved 1.00 0.00 0.00 Textual Information(3)
12 Wockhardt Limited Wockhardt Bio Ag Subsidiary Sale of goods or services 4,33,674.00 Approved 11,730.00 0.00 0.00
13 Wockhardt Limited CP Pharmaceuticals Limited Step down subsidiary Sale of goods or services 4,33,674.00 Approved 43.00 0.00 0.00
14 Wockhardt Limited Wockhardt Bio (R) LLC Step down subsidiary Sale of goods or services 27,900.00 Approved 1,360.00 0.00 0.00
15 Wockhardt Limited Pinewood Laboratories Ltd Step down subsidiary Sale of fixed assets 4,33,674.00 Approved 107.00 0.00 0.00
16 Wockhardt Limited Wockhardt Infrastructure Development Limited Wholly Owned Subsidiary Purchase of goods or services 0.00 Not Applicable 782.00 0.00 0.00
17 Wockhardt Limited Wockhardt Infrastructure Development Limited Wholly Owned Subsidiary Purchase of goods or services 0.00 Not Applicable 761.00 0.00 0.00
18 Wockhardt Limited Wockhardt Infrastructure Development Limited Wholly Owned Subsidiary Purchase of goods or services 0.00 Not Applicable 1.00 0.00 0.00
19 Wockhardt Limited Wockhardt Infrastructure Development Limited Wholly Owned Subsidiary Any other transaction Recovery of Support Service Cost 0.00 Not Applicable 6.00 0.00 0.00
20 Wockhardt Limited Wockhardt Bio Ag Subsidiary Any other transaction Reimbursement received 0.00 Not Applicable 10.00 0.00 0.00
21 Wockhardt Limited CP Pharmaceuticals Limited Step down subsidiary Any other transaction Reimbursement received 0.00 Not Applicable 4.00 0.00 0.00
22 Wockhardt Limited Wockhardt UK Limited Step down subsidiary Any other transaction Reimbursement received 0.00 Not Applicable 29.00 0.00 0.00
23 Wockhardt Limited Pinewood Laboratories Ltd Step down subsidiary Any other transaction Reimbursement received 0.00 Not Applicable 22.00 0.00 0.00
24 Wockhardt Limited Wockhardt Bio (R) LLC Step down subsidiary Any other transaction Reimbursement received 0.00 Not Applicable 6.00 0.00 0.00
25 Wockhardt Limited Wockhardt Bio Ag Subsidiary Any other transaction Reimbursement paid 0.00 Not Applicable 84.00 0.00 0.00
26 Wockhardt Limited CP Pharmaceuticals Limited Step down subsidiary Any other transaction Reimbursement paid 0.00 Not Applicable 10.00 0.00 0.00
27 Wockhardt Limited Wockhardt UK Limited Step down subsidiary Any other transaction Reimbursement paid 0.00 Not Applicable 32.00 0.00 0.00
28 Wockhardt Limited Wockhardt Bio (R) LLC Step down subsidiary Any other transaction Reimbursement paid 0.00 Not Applicable 141.00 0.00 0.00
29 Wockhardt Limited Wockhardt Bio (R) LLC Step down subsidiary Any other transaction Advances Received against Export of Goods 5,000.00 Approved 845.00 0.00 0.00
30 Wockhardt Limited Wockhardt Bio (R) LLC Step down subsidiary Any other transaction Advances adjusted against Export of Goods and Services 5,000.00 Approved 1,014.00 0.00 0.00
31 Wockhardt Limited Khorakiwala Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Loan 1,50,000.00 Approved 1,180.00 29,770.00 30,950.00
32 Wockhardt Limited Khorakiwala Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Interest Expense 1,50,000.00 Approved 1,234.00 5,459.00 5,691.00
33 Wockhardt Limited Khorakiwala Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Interest paid 1,50,000.00 Approved 1,002.00 0.00 0.00
34 Wockhardt Limited Khorakiwala Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Lease Rent Income 20.00 Approved 6.00 0.00 0.00
35 Wockhardt Limited Khorakiwala Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Recovery of Support Service Cost 20.00 Approved 6.00 0.00 0.00
36 Wockhardt Limited Merind Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Loan Repaid 0.00 Not Applicable 5.00 0.00 0.00
37 Wockhardt Limited Merind Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Interest Expense 26,000.00 Approved 467.00 3,123.00 3,126.00
38 Wockhardt Limited Merind Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Interest paid 26,000.00 Approved 464.00 0.00 0.00
39 Wockhardt Limited Merind Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Recovery of Support Service Cost 20.00 Approved 6.00 0.00 0.00
40 Wockhardt Limited Themisto Trustee Company Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Interest Expense 26,000.00 Approved 121.00 0.00 121.00
41 Wockhardt Limited Ananke Trustee Company Pvt Ltd Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Interest Expense 26,000.00 Approved 1,189.00 4,524.00 5,042.00
42 Wockhardt Limited Ananke Trustee Company Pvt Ltd Enterprises over which Key Managerial Personnel exercise significant influence/control Interest paid 26,000.00 Approved 672.00 0.00 0.00
43 Wockhardt Limited Callirhoe Trustee Company Pvt Ltd Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Loan Repaid 0.00 Not Applicable 3,220.00 0.00 0.00
44 Wockhardt Limited Callirhoe Trustee Company Pvt Ltd Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Interest Expense 26,000.00 Approved 484.00 5,203.00 4,909.00
45 Wockhardt Limited Callirhoe Trustee Company Pvt Ltd Enterprises over which Key Managerial Personnel exercise significant influence/control Interest paid 26,000.00 Approved 778.00 0.00 0.00
46 Wockhardt Limited Palanpur Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Interest Expense 26,000.00 Approved 804.00 1,858.00 2,477.00
47 Wockhardt Limited Palanpur Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Interest paid 26,000.00 Approved 184.00 0.00 0.00
48 Wockhardt Limited Carol Info Services Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Purchase of goods or services 27,900.00 Approved 4,600.00 0.00 0.00
49 Wockhardt Limited Carol Info Services Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Sale of goods or services 27,900.00 Approved 20.00 0.00 0.00
50 Wockhardt Limited Carol Info Services Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Reimbursement paid 0.00 Not Applicable 53.00 0.00 0.00
51 Wockhardt Limited Wockhardt Hospitals Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Sale of goods or services 27,900.00 Approved 1.00 0.00 0.00 Textual Information(4)
52 Wockhardt Limited Wockhardt Regenerative Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Purchase of goods or services 27,900.00 Approved 726.00 0.00 0.00
53 Wockhardt Limited Dr. Habil Khorakiwala Education and Health Foundation ( Trust) [Wockhardt Global School] Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Reimbursement paid 0.00 Not Applicable 172.00 0.00 0.00
54 Wockhardt Limited Palanpur Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Purchase of goods or services 27,900.00 Approved 46.00 0.00 0.00
55 Wockhardt Limited Palanpur Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Recovery of Support Service Cost 20.00 Approved 6.00 0.00 0.00
56 Wockhardt Limited Dr. Habil F. Khorakiwala Executive Chairman Remuneration 500.00 Approved 215.00 0.00 0.00
57 Wockhardt Limited Dr. Huzaifa H. Khorakiwala Executive Director Remuneration 280.00 Approved 118.00 0.00 0.00
58 Wockhardt Limited Dr. Murtaza H. Khorakiwala Managing Director Remuneration 280.00 Approved 109.00 0.00 0.00
59 Wockhardt Limited CP Pharmaceuticals Limited Step down subsidiary Any other transaction Receivables (Balances) 0.00 Not Applicable 0.00 199.00 282.00
60 Wockhardt Limited Z&Z Services GmbH Step down subsidiary Any other transaction Receivables (Balances) 0.00 Not Applicable 0.00 9.00 11.00
61 Wockhardt Limited Wockhardt USA LLC Step down subsidiary Any other transaction Receivables (Balances) 0.00 Not Applicable 0.00 380.00 399.00
62 Wockhardt Limited Wockhardt Bio Pty Limited Step down subsidiary Any other transaction Receivables (Balances) 0.00 Not Applicable 0.00 2.00 2.00
63 Wockhardt Limited Wockhardt Bio AG Subsidiary Any other transaction Receivables (Balances) 0.00 Not Applicable 0.00 36,519.00 52,648.00
64 Wockhardt Limited Wockhardt UK Limited Step down subsidiary Any other transaction Receivables (Balances) 0.00 Not Applicable 0.00 583.00 682.00
65 Wockhardt Limited Pinewood Laboratories Limited Step down subsidiary Any other transaction Receivables (Balances) 0.00 Not Applicable 0.00 837.00 1,001.00
66 Wockhardt Limited Wockhardt Bio (R) LLC Step down subsidiary Any other transaction Receivables (Balances) 0.00 Not Applicable 0.00 527.00 343.00
67 Wockhardt Limited Morton Grove Pharmaceuticals Step down subsidiary Any other transaction Receivables (Balances) 0.00 Not Applicable 0.00 312.00 325.00
68 Wockhardt Limited Wockhardt Farmaceutica SA DE CV Step down subsidiary Any other transaction Receivables (Balances) 0.00 Not Applicable 0.00 637.00 662.00
69 Wockhardt Limited CP Pharmaceuticals Limited Step down subsidiary Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 1,326.00 1,731.00
70 Wockhardt Limited Wockhardt USA LLC Step down subsidiary Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 989.00 1,027.00
71 Wockhardt Limited Wockhardt Bio AG Subsidiary Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 4,764.00 4,930.00
72 Wockhardt Limited Wockhardt UK Limited Step down subsidiary Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 595.00 675.00
73 Wockhardt Limited Pinewood Laboratories Limited Step down subsidiary Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 594.00 673.00
74 Wockhardt Limited Wockhardt Bio (R) LLC Step down subsidiary Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 1,085.00 1,164.00
75 Wockhardt Limited Morton Grove Pharmaceuticals Step down subsidiary Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 339.00 352.00
76 Wockhardt Limited Wockhardt Infrastructure Development Limited Wholly Owned Subsidiary Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 11,335.00 12,071.00
77 Wockhardt Limited CP Pharmaceuticals Limited Step down subsidiary Any other transaction Payables for Capital Goods (Balances) 0.00 Not Applicable 0.00 302.00 326.00
78 Wockhardt Limited Pinewood Laboratories Limited Step down subsidiary Any other transaction Payables for Capital Goods (Balances) 0.00 Not Applicable 0.00 94.00 106.00
79 Wockhardt Limited Wockhardt Bio AG Subsidiary Any other transaction Payables for Capital Goods (Balances) 0.00 Not Applicable 0.00 2,770.00 6,811.00
80 Wockhardt Limited CP Pharmaceuticals Limited Step down subsidiary Any other transaction Other Liability (Balances) 0.00 Not Applicable 0.00 272.00 319.00
81 Wockhardt Limited Wockhardt Bio (R) LLC Step down subsidiary Any other transaction Advances from Subsidiaries Against Supply (Balances) 0.00 Not Applicable 0.00 697.00 528.00
82 Wockhardt Limited Wockhardt Bio AG Subsidiary Any other transaction Advances from Subsidiaries Against Supply (Balances) 0.00 Not Applicable 0.00 1,674.00 1,674.00
83 Wockhardt Limited Wockhardt Bio AG Subsidiary Any other transaction Guarantee Fees Receivable (Balances) 0.00 Not Applicable 0.00 4,112.00 3,952.00
84 Wockhardt Limited Wockhardt Infrastructure Development Limited Wholly Owned Subsidiary Any other transaction Security Deposit Given (Balances) 0.00 Not Applicable 0.00 685.00 685.00
85 Wockhardt Limited Morton Grove Pharmaceuticals Step down subsidiary Any other transaction Other Receivables (Expense Recovery Balances) 0.00 Not Applicable 0.00 611.00 635.00
86 Wockhardt Limited Wockhardt Infrastructure Development Limited Wholly Owned Subsidiary Any other transaction Other Receivables (Expense Recovery Balances) 0.00 Not Applicable 0.00 191.00 197.00
87 Wockhardt Limited Wockhardt Bionova Limited Wholly Owned Subsidiary Any other transaction Other Receivables (Expense Recovery Balances) 0.00 Not Applicable 0.00 3.00 3.00
88 Wockhardt Limited Wockhardt Medicines Limited Wholly Owned Subsidiary Any other transaction Other Receivables (Expense Recovery Balances) 0.00 Not Applicable 0.00 6.00 6.00
89 Wockhardt Limited Pinewood Laboratories Limited Step down subsidiary Any other transaction Other Receivables (Expense Recovery Balances) 0.00 Not Applicable 0.00 0.00 122.00
90 Wockhardt Limited CP Pharmaceuticals Limited Step down subsidiary Any other transaction Advance paid 0.00 Not Applicable 0.00 0.00 44.00
91 Wockhardt Limited Wockhardt Hospitals Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 26.00 26.00
92 Wockhardt Limited Wockhardt Regenerative Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 97.00 97.00
93 Wockhardt Limited Wockhardt Regenerative Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 0.00 335.00
94 Wockhardt Limited Carol Info Services Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 206.00 268.00
95 Wockhardt Limited Wockhardt Hospitals Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 63.00 0.00
96 Wockhardt Limited Palanpur Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 662.00 712.00
97 Wockhardt Limited Merind Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Payables (Balances) 0.00 Not Applicable 0.00 1.00 1.00
98 Wockhardt Limited Merind Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Balanaces (Loan) 0.00 Not Applicable 0.00 13,416.00 13,411.00
99 Wockhardt Limited Themisto Trustee Company Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Balanaces (Loan) 0.00 Not Applicable 0.00 1,946.00 1,946.00
100 Wockhardt Limited Ananke Trustee Company Pvt Ltd Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Balanaces (Loan) 0.00 Not Applicable 0.00 22,064.00 22,064.00
101 Wockhardt Limited Callirhoe Trustee Company Pvt Ltd Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Balanaces (Loan) 0.00 Not Applicable 0.00 14,847.00 11,627.00
102 Wockhardt Limited Palanpur Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Balanaces (Loan) 0.00 Not Applicable 0.00 15,778.00 15,778.00
103 Wockhardt Limited Carol Info Services Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Security Deposit Given (Balances) 0.00 Not Applicable 0.00 5,550.00 5,550.00
104 Wockhardt Limited Palanpur Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Security Deposit Given (Balances) 0.00 Not Applicable 0.00 275.00 275.00
105 Wockhardt Limited Wockhardt Regenarative Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 2.00 2.00
106 Wockhardt Limited Carol Info Services Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 92.00 114.00
107 Wockhardt Limited Khorakiwala Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 218.00 231.00
108 Wockhardt Limited Palanpur Holdings and Investments Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 91.00 97.00
109 Wockhardt Limited Denarius Estate Development Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
110 Wockhardt Limited Dr. Habil Khorakiwala Education and Health Foundation (Section 8) Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
111 Wockhardt Limited Adrastea Trading and Services LLP Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
112 Wockhardt Limited Lysithea Consultants Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
113 Wockhardt Limited Lysithea Discretionary Trust Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
114 Wockhardt Limited Themisto Trustee Company Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
115 Wockhardt Limited Banneret Trading Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
116 Wockhardt Limited HZ Trading and Services LLP Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
117 Wockhardt Limited HNZ Discretionary Trust Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
118 Wockhardt Limited Dartmour Holdings Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
119 Wockhardt Limited Amadou Estate Development Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
120 Wockhardt Limited Callirhoe Trustee Company Privated Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
121 Wockhardt Limited Shravan Constructions Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
122 Wockhardt Limited Holmdene Constructions Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 17.00 17.00
123 Wockhardt Limited Sharanya Chemicals And Pharmaceuticals Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
124 Wockhardt Limited HNZ Trading and Services LLP Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
125 Wockhardt Limited HNZ Consultants Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
126 Wockhardt Limited Khorakiwala Foundation Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
127 Wockhardt Limited Ananke Trustee Company Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
128 Wockhardt Limited Pasithee Trustee Company Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
129 Wockhardt Limited Megaclite Trading Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
130 Wockhardt Limited Genista Trading and Services Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
131 Wockhardt Limited Impala Advisory Services Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
132 Wockhardt Limited Sinope Advisory Services Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
133 Wockhardt Limited Step Forward Advisory Services Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
134 Wockhardt Limited Kendo Advisory Services Private Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
135 Wockhardt Limited Lysithea Trading and Services LLP Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
136 Wockhardt Limited Helike Trading and Services LLP Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
137 Wockhardt Limited Amalthea Consultants Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
138 Wockhardt Limited Amalthea Trading and Services LLP Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
139 Wockhardt Limited Amalthea Discretionary Trust Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
140 Wockhardt Limited Dr. Habil Khorakiwala Education and Health Foundation ( Trust) [Wockhardt Global School] Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 548.00 548.00
141 Wockhardt Limited Wockhardt Foundation Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 1.00 1.00
142 Wockhardt Limited Merind Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 91.00 97.00
143 Wockhardt Limited Wockhardt Hospitals Limited Enterprises over which Key Managerial Personnel exercise significant influence/control Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
144 Wockhardt Limited Humuza Consultants Promoter Entity Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
145 Wockhardt Limited Habil Khorakiwala Trust Promoter Group Entity Any other transaction Other Receivables (Balances) 0.00 Not Applicable 0.00 10.00 10.00
146 Wockhardt Infrastructure Development Limited Wockhardt Medicines Limited Fellow Subsidiary Any other transaction Balances (Loan) 0.00 Not Applicable 0.00 16.00 16.00
147 Wockhardt Infrastructure Development Limited Wockhardt Medicines Limited Fellow Subsidiary Any other transaction Interest Expense 0.00 Not Applicable 1.00 1.00 2.00 Textual Information(5)
148 Wockhardt Bio AG Wockahardt Bio Pty Ltd, Australia Subsidiary Any other transaction Debtors 0.00 Not Applicable 0.00 8.00 89.00
149 Wockhardt Bio AG Wockahardt Bio Pty Ltd, Australia Subsidiary Any other transaction Advance recceived for supplies 0.00 Not Applicable 0.00 292.00 319.00
150 Wockhardt Bio AG Wockahardt Bio Pty Ltd, Australia Subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 53.00 58.00
151 Wockhardt Bio AG Wockahardt Bio Pty Ltd, Australia Subsidiary Sale of goods or services 26,000.00 Approved 66.00 0.00 0.00
152 Wockhardt Bio AG Z & Z Services GmbH, Germany Subsidiary Any other transaction Balances (Loan) 0.00 Not Applicable 0.00 115.00 134.00
153 Wockhardt Bio AG Wockhardt Europe Limited Fellow Subsidiary Any other transaction Balances (Loan) 0.00 Not Applicable 0.00 1,020.00 1,479.00
154 Wockhardt Bio AG CP Pharmaceuticals Limited Subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 40,016.00 46,003.00
155 Wockhardt Bio AG CP Pharmaceuticals Limited Subsidiary Sale of goods or services 4,33,674.00 Not Applicable 1,561.00 0.00 0.00
156 Wockhardt Bio AG CP Pharmaceuticals Limited Subsidiary Purchase of goods or services 4,33,674.00 Not Applicable 17,667.00 0.00 0.00
157 Wockhardt Bio AG CP Pharmaceuticals Limited Subsidiary Any other transaction Reimbursement 0.00 Not Applicable 3,500.00 0.00 0.00
158 Wockhardt Bio AG Wockhardt Farmaceutica SA DE CV Subsidiary Any other transaction Debtors 0.00 Not Applicable 0.00 10,523.00 10,932.00
159 Wockhardt Bio AG Wockhardt Farmaceutica SA DE CV Subsidiary Any other transaction Balances (Loan) 0.00 Not Applicable 0.00 2,487.00 2,584.00
160 Wockhardt Bio AG Wockahrdt USA LLC Step down subsidiary Any other transaction Debtors 0.00 Not Applicable 0.00 61,230.00 0.00
161 Wockhardt Bio AG Wockahrdt USA LLC Step down subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 225.00 0.00
162 Wockhardt Bio AG Wockahrdt UK Limited Subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 93.00 1,277.00
163 Wockhardt Bio AG Wockahrdt UK Limited Subsidiary Any other transaction Debtors 0.00 Not Applicable 0.00 1,208.00 8,749.00
164 Wockhardt Bio AG Wockahrdt UK Limited Subsidiary Sale of goods or services 4,33,674.00 Appoved 27,299.00 0.00 0.00
165 Wockhardt Bio AG Wockhardt Bio (R) LLC Subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 1.00 1.00
166 Wockhardt Bio AG Pinewood Laboratories Limited Step down subsidiary Any other transaction Debtors 0.00 Not Applicable 0.00 0.00 125.00
167 Wockhardt Bio AG Pinewood Laboratories Limited Step down subsidiary Any other transaction Balances (Loan) 0.00 Not Applicable 0.00 3,451.00 3,912.00
168 Wockhardt Bio AG Pinewood Laboratories Limited Step down subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 2,675.00 2,988.00
169 Wockhardt Bio AG Pinewood Laboratories Limited Step down subsidiary Sale of goods or services 4,33,674.00 Appoved 338.00 0.00 0.00
170 Wockhardt Bio AG Pinewood Laboratories Limited Step down subsidiary Any other transaction Interest Expense 0.00 Not Applicable 192.00 0.00 0.00
171 Wockhardt Bio AG Morton Grove Pharmaceuticals Inc. (consolidated) Step down subsidiary Any other transaction Debtors 0.00 Not Applicable 0.00 48.00 0.00
172 Wockhardt Bio AG Morton Grove Pharmaceuticals Inc. (consolidated) Step down subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 51,386.00 0.00
173 Wockhardt Bio AG Morton Grove Pharmaceuticals Inc. (consolidated) Step down subsidiary Any other transaction Reimbursement 0.00 Not Applicable 502.00 0.00 0.00
174 CP Pharmaceuticals Limited Wockhardt UK Holdings Limited Fellow Subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 8,088.00 8,730.00
175 CP Pharmaceuticals Limited Wockhardt UK Holdings Limited (consolidated) Fellow Subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 3,003.00 3,242.00
176 CP Pharmaceuticals Limited Pinewood Laboratories Limited Fellow Subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 1,740.00 1,531.00
177 CP Pharmaceuticals Limited Pinewood Laboratories Limited Fellow Subsidiary Purchase of goods or services 7,000.00 Appoved 1,479.00 0.00 0.00
178 CP Pharmaceuticals Limited Pinewood Laboratories Limited Fellow Subsidiary Any other transaction Advance given 0.00 Not Applicable 0.00 332.00 338.00
179 CP Pharmaceuticals Limited Pinewood Laboratories Limited Fellow Subsidiary Any other transaction Debtors 0.00 Not Applicable 0.00 0.00 6.00
180 CP Pharmaceuticals Limited Wockahrdt UK Limited Fellow Subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 0.00 652.00
181 CP Pharmaceuticals Limited Wockahrdt UK Limited Fellow Subsidiary Any other transaction Debtors 0.00 Not Applicable 0.00 761.00 48.00
182 CP Pharmaceuticals Limited Wockahrdt UK Limited Fellow Subsidiary Any other transaction Reimbursement 0.00 Not Applicable 289.00 0.00 0.00
183 CP Pharmaceuticals Limited Pinewood Healthcare Limited Fellow Subsidiary Any other transaction Debtors 0.00 Not Applicable 0.00 0.00 10.00
184 Wockhardt UK Holdings Limited (Consolidated) Wockhardt Farmaceutica Do Brasil Ltda Subsidiary Any other transaction Balances (Loan) 0.00 Not Applicable 0.00 153.00 165.00
185 Wockhardt UK Limited Pinewood Healthcare Limited Fellow Subsidiary Any other transaction Debtors 0.00 Not Applicable 0.00 28.00 39.00
186 Wockhardt UK Limited Pinewood Laboratories Limited Fellow Subsidiary Any other transaction Debtors 0.00 Not Applicable 0.00 168.00 64.00
187 Wockpharma Ireland Limited Pinewood Laboratories Limited Subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 15,153.00 16,257.00
188 Wockpharma Ireland Limited Pinewood Laboratories Limited Subsidiary Dividend received 0.00 Not Applicable 885.00 0.00 0.00
189 Morton Grove Pharmaceuticals Inc. (consolidated) Wockahrdt USA LLC Step down subsidiary Any other transaction Balances (Loan) 0.00 Not Applicable 0.00 9,830.00 0.00
190 Morton Grove Pharmaceuticals Inc. (consolidated) Wockahrdt USA LLC Subsidiary Any other transaction Payables (Debtors) 0.00 Not Applicable 0.00 7,741.00 0.00
191 Morton Grove Pharmaceuticals Inc. (consolidated) Wockahrdt USA LLC Subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 5,076.00 0.00
192 Wockhardt Farmaceutica SA DE CV Wockhardt Services SA DE CV Fellow Subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 875.00 909.00
193 Wockhardt Service SA DE CV Wockhardt Bio AG Parent Company Any other transaction Payables 0.00 Not Applicable 0.00 402.00 418.00
194 Wockhardt UK Holdings Limited (consolidated) CP Pharmaceuticals Limited Fellow subsidiary Any other transaction Payables 0.00 Not Applicable 0.00 67.00 72.00
195 Wockhardt Bio AG Wockahrdt USA LLC Step down subsidiary Any other transaction Reimbursement 0.00 Not Applicable 35.00 0.00 0.00
196 Morton Grove Pharmaceuticals Inc. (consolidated) Wockahrdt USA LLC Step down subsidiary Any other transaction Reimbursement 0.00 Not Applicable 331.00 0.00 0.00
Total value of transaction during the reporting period 1,13,477.00



Text Block

Textual Information(1) 1. Differences in the opening and closing balances may be reflected due to Fluctuations in the Exchange Rate. Please note exchange rate as considered below: a. For Opening balance Exchange Rate is considered as on April 01, 2025. b. For Closing balance Exchange Rate is considered as on September 30, 2025. c. For the value of transactions during the period, Average Exchange Rate is considered. 2. The value of the related party transaction approved by the audit committee is shown as '0' which does not required approval of Audit Committee as per SEBI LODR Regulations, 2015.
Textual Information(2) The Actual value of transaction is Rs. 0.008 Crores
Textual Information(3) The Actual value of transaction is Rs. 0.004 Crores
Textual Information(4) The Actual Transaction value is Rs. 0.002 Crores
Textual Information(5) The Actual value of transaction is 0.005 crores